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ABSTRACT
Quality management systems (QMS) are becoming a global paradigm especially in testing laboratories. A critical
component of QMS in testing laboratories is the proper handling of in-coming samples to ensure that the
integrity of such samples are not compromised in any way before the commencement of testing and assure the
validity of the results received from testing units. The sample reception unit in the Central Registry of the Central
Drug Control Laboratory (CDCL) of the National Agency of Food and Drug Administration and Control
(NAFDAC), Nigeria, did not have a QMS in place. The methodology for instituting QMS involved reorganization
of the unit, development of all working documents, training and retraining of all staff/team members,
implementation of the new system and then conducting continuous monitoring and evaluation using predefined
key performance indicators. The results clearly show that the implementation of a QMS in the Sample Reception
unit of the Central Registry of the Central Drug Control Laboratory has greatly improved the overall effectiveness
and efficiency of the unit. It has ensured that the integrity of incoming samples is not compromised before testing
by the analytical units. This has led to increased trust and reliability of the test results and analytical reports
produced by the Central Drug Control Laboratory of the National Agency for Food and Drugs Administration and
Control of Nigeria.
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INTRODUCTION
Quality management systems are becoming a global
paradigm. All processes/organizations are
implementing the principles of quality management
systems to improve the quality and efficiency of their
work output. Most testing laboratories are in the
forefront of implementing QMS.
In most laboratories around the world, the handling
of in-coming samples (e.g. biological specimen,
chemical samples, raw materials or finished
pharmaceutical products) all require appropriate
care. These are to ensure that the integrity of the
samples is not compromised in any way and assure
the validity of the results received from testing units.
Thus there is a general realization that the
processes involved in the management of incoming
samples are critical and should be under control if
reliable results are to be obtained from testing.
To this end, the World Health Organization (WHO),
the International Organization for Standards (ISO)
and most National Drug Regulatory Authorities have
guidelines for the proper handling of in-coming
samples to laboratories.
A number of researches have been done in the area
of handling biological specimens and chemicals of
various types, however not much research has been
done on the receipt of finished pharmaceutical
products to pharmaceutical testing laboratories.

Research Question/ Hypothesis
Will the institutionalization of a quality management
system in the Central Registry unit of the Central
Drug Laboratory of NAFDAC improve the overall
performance and quality of work of the unit?
My hypotheses is that the institutionalization of a
quality management system in the Central Registry
unit of the Central Drug Laboratory of NAFDAC will
improve its overall performance and quality of work.

Significance of the Problem
The Central Drug Control Laboratory has the
enormous responsibility of assuring that the
populace uses only quality, safe and efficacious
medicines by making pronouncements on the quality
and effectiveness of medicines after appropriate
quality control checks. These quality control checks
must be done following approved international
standards. Third world countries like Nigeria is
battling with the growing menace of spuriously

labeled and fake medicines that lead to treatment
failures, drug resistant disease, and deaths among
the populace. Nigeria, with a population of over 190
million people, has become a dumping ground for
various manufacturers of medicinal product,
especially from Asia. The populace must be
protected from this menace by a strong and stringent
regulatory body of which a quality control laboratory
is part. Thus all analytical work done in the
laboratory has impact on the overall healthcare
system of the country. However its assessment
process starts at the sample reception area of the
central registry unit of the laboratory. If samples are
not properly handled in accordance with international
standards at this point, it invalidates all other
processes of the laboratory ab-initio. It is an
identified critical control point in the health care
system of the country. It is therefore imperative that it
must be structured to meet international standards
for quality management systems.
Also for the laboratory to attain and retain World
Health Organization pre-qualification status, it has to
implement quality management system in this unit

RESULTS OF LITERATURE SEARCH
The literature search revealed that there is a dearth
of scholarly work in the area of receipt, handling and
storage of pharmaceutical products prior to analysis
in testing laboratories.
However, a handful amount of work has been done
in the area of handling and management of
biological samples such as blood, urine etc.
submitted to medical laboratories for testing.
There are research works and papers on how to
implement quality management systems in
laboratories in general. A number of researches
have also been done to assess the impact of
implementing quality management systems in
different processes.
All the literature reviewed revealed that improper
handling of incoming test samples has impact on the
test results.
The article ‘Effects of sample handling and storage
on quantitative lipid analysis in human serum’ written
by Zikovic et al revealed that ‘proper storage and
handling of samples is paramount to retaining their
informativeness’ (Zivkovic et al., 2009). The
researcher explored the effects of various storage
and handling conditions such as freeze-thaw,
extraction state, and storage temperatures, prior to
the quantification of density-based lipoprotein
fractionations. The same equipment was used to
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analyze the samples to eliminate any equipment
sensitivity bias.
Studies by other investigators have corroborated this
finding. Harsten et al showed that the way blood
samples are handled significantly affected the results
of blood gas analysis (Harsten, Berg, Inerot, & Muth,
1988). Kozikwoski et al studied “the effect of room
temperature storage on the stability of compounds
stored in DMSO”. The stability of approximately 7200
compounds stored as 20-mM DMSO solutions under
ambient conditions was monitored for 1 year. The
compound’s integrity was measured by flow injection
analysis using positive and negative electrospray
ionization mass spectrometry. Each sample was
assessed at the beginning of the study, after 12
months of storage, and at a randomized time point
between the initial and final time points of the study.
The study showed a gradual decrease in the integrity
of the compounds (Kozikowski et al., 2003). The
data obtained by Busch et al in their study of the
impact of specimen handling and storage on
detection of Hepatitis C virus RNA further confirms
that well controlled sample handling and storage
processes are important to the quality of results
obtained from the quantitative analysis of blood
samples from patients who were positive on antiHCV supplemental blood test (Busch, Wilber,
Johnson, Tobler, & Evans, 1992).
There are however, clear guidelines on the proper
handling of in-coming finished pharmaceutical
products tested at pharmaceutical control
laboratories. The guidelines reviewed were
1. World Health organization good practices for
pharmaceutical quality control laboratories
2. ISO/IEC 17025 - General requirements for
the competence of testing and calibration
laboratories
Part 2, section 14 of the WHO guidelines gives clear
directives for the proper handling of in-coming
samples to pharmaceutical quality control
laboratories. Samples received by the laboratory
may be for compliance testing or for investigative
testing. Samples for compliance testing include
routine samples for control, samples suspected of
not complying with the specifications or samples
submitted in connection with a marketing
authorization process (World Health Organization,
2010). A properly filled test request form should
accompany all samples. Samples should be checked
for any damages and matched with the information
on the test request forms. All samples should be
logged into a computerized system and given unique
identification numbers. Samples should be stored in

accordance with their recommended storage
conditions while awaiting forwarding to testing units.
There should be proper segregation of samples to
avoid cross contaminations (World Health
Organization, 2010)
Similarly, section 5.8 of the ISO/IEC 17025 - General
requirements for the competence of testing and
calibration laboratories expounded on the handling
of test and calibration items. Section 5.8.1 states
“The laboratory shall have procedures for the
transportation, receipt, handling, protection, storage,
retention and/or disposal of test and/or calibration
items, including all provisions necessary to protect
the integrity of the test or calibration item, and to
protect the interests of the laboratory and the
customer”(ISO, 2005). It also has requirements for
unique identification of samples, segregation of
samples to avoid cross contamination and
maintenance of adequate records.
These guidelines underscore the importance of
appropriate handling of all incoming samples. Any
discrepancies at this point will affect all the validity of
the test results. Implementation of these guidelines
is part of the institutionalization of quality
management systems in a drug-testing laboratory.
It is generally agreed in the literature that the
implementation of quality management systems in
any organization or process will lead to an
improvement in the operational systems of that
organization. The article “The Impact of ISO 9000
Quality Management Systems on Manufacturing”
attests to this. The research showed a significant
improvement in the performance of certified
companies (i.e. companies that have implemented
ISO 9000 Quality Management Systems) over those
that are not certified (Tufan, 2007). 106 small and
medium sized companies were examined of which
79 of them had implemented ISO 9000 standards.
Melnyk Steven et al, in their study of assessing the
impact of environmental management systems on
corporate and environmental performance also
supports this theory (Melnyk, Sroufe, & Calantone,
2003). Their results shows that firms that have EMS
and ISO 14001 certification have greater impact on
performance than firms who do not. Hongyi in his
research paper showed that there is a relationship
between the implementation of TQM and ISO
standards and an improvement in performance of
the organization.(Hongyi, 2000). Other reseachers
that support this idea are Kaynak Hale (Hale, 2003)
and Rao et al (Rao, Ragu-Nathan, & Solis, 1997).
Konovalova and Popova concluded that
implementation of quality management systems in
drug testing laboratories leads to the production of
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quality results in time frames agreed with the clients
using accepted testing methods. This in turn leads to
customer satisfaction (Konovalova & Popova, 2010).

METHOD

The literatures revealed that the successful
implementation of any quality management system
is dependent on the framework of the
implementation process. It is important to formulate
a sound implementation framework prior to the
embarking on such a change. It will be important to
take into cognizance the systems on ground in the
organization and construct a stepwise
implementation framework that will have positive
impact on the system. (Yusof & Aspinwall, 2010).
This thought is supported by studies conducted by
Andiric and Massambu. They studied the
improvement of laboratory quality in Tanzania. The
study showed that the improvement plan consisted
of formalized hands-on training under the
Strengthening Laboratory Management Toward
Accreditation program (SLMTA) that teaches the
tasks and skills of laboratory management and
provides the tools for implementation of best
laboratory practice. (Andiric & Massambu, 2015).
Other researchers that support this thought are Yao
et al (Yao et al., 2010). Groucher et al, in their peer
reviewed article - “A process approach to ISO/IEC
17025 in the implementation of a quality
management system in testing laboratories”, showed
that implementation of quality management systems
require a stepwise approach (Grochau & ten Caten,
2012).

It is a quantitative type of research using a
retrospective-prospective study design. The
following data sets will be collected-

Design And Implementation

•

Retrospective data- this is a quantitative
secondary type of data that will be acquired
from the audit reports before the
intervention. We will extract the number and
type of non-conformances of the unit.

•

Prospective data – it is a quantitative data.
There are 2 sets of data that will be collected
viz▪

Measurement of KPIs

▪

Number of non-conformances after the
implementation of quality systems in the
unit

To implement quality systems in the sample
reception area of the central registry unit, the
following were done:
•

Restructuring of the unit to perform all its
expected functions (Organograms, Job
descriptions)

•

Development of all relevant quality
documents (SOPs, Work Instructions, etc)

•

Training of all staff

•

Test run of the new SOPs

•

Review of the SOPs

•

Full deployment of the new system

•

Monthly evaluation of the new system using
KPIs (clearly defined KPIs will be developed)

•

Periodic self-audits of the unit

•

Scheduled audits by the Quality Assurance
Manager of the Central Drug Control
Laboratory

•

Other audits by external bodies e.g WHO
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Monitoring
The implementation of quality management systems
in the Sample reception unit was monitored using
clearly defined KPIs outlined below
1. 95% compliance in inputting all in-coming
samples into the Electronic laboratory
system of the Central Drug Control
Laboratory within 72 hours
2. 95% error free (right-first-time) entries of
sample data logged into the Electronic
laboratory system of the Central Drug
Control Laboratory
3. 70% reduction in the severity of nonconformances from the Sample Reception
unit
4. The environment of the storage area of incoming samples should be monitored twice
daily

coming samples into the Electronic laboratory
system of the Central Drug Control Laboratory within
72 hours. This criterion was not met

Table 1- Percentage of Samples inputted into the
system within 72hrs
Month

Percentage of Samples Inputted
Into The System within 72hours

May

37

June

45

July

68

August

79

September

12.9

October

25.6

5. The percentage of samples damaged during
handling at the sample reception area of the
Central Registry should be less than 1% of
the total number of samples received.

RESULTS
Statistical methods were used to analyze and
present the data obtained from monitoring the
implementation of quality management systems. The
number and types of non-conformances observed
from the various audits, before and after the
implementation of the Quality Management System
were compared.
The KPIs measured were charted to determine
whether there is continuous improvement in the
system. The findings are presented below.

Percentage of Samples Inputted into the
System within 72hrs
This parameter, or KPI, helps to measure the
efficiency of the sample reception process, that is,
how fast the unit is able to process samples and
input their details on the Electronic lab. From the
chart, it is clear that there was an initial increase in
efficiency between the months of May (37%) to
August (79%) and then a sharp decline in
September (12.9%), followed by a moderate
improvement in October (25.6%). The set criterion
for this KPI is 95% compliance in inputting all in-

Figure 1- Percentage of Samples inputted into the System Within
72hrs.

Percentage of Error Free (Right-FirstTime) Entries.
This KPI seeks to measure the effectiveness of the
unit in handling the sample receipt process.
The chart shows a steady increase in the percentage
of error free entries. At the beginning of the
measurement of this KPI, there was a 90% error free
entry. However as of October, we had a 98.14%
error free entry. The set criterion for this KPI is 95%
error free entries of sample data logged into the
Electronic laboratory system of the Central Drug
Control Laboratory. The unit exceeded the set
criterion. This implies that the unit is becoming more
effective in handling the sample receipt process.
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Table 2- Percentage of Error Free Entries
Month

Percentage of Error Free Entries

July

90

August

93.88

September

96.36

October

98.14

Table 3- Number and Type of Non-Conformances
Type of Audit

Number of Non-Conformances
Major

Minor

Total

WHO
Assessment
2006

8

0

8

Internal Audit
by QA March
2015

5

2

7

WHO Peer
Audit August
2015

1

2

3

Figure 2 Percentage of Error Free Entries.

Number and Type of Non-Conformances
This parameter is one of the true tests of the
successful implementation of quality management
systems. Konovalova and Popova stated that one of
the main sources of information for the evaluation of
the effectiveness of the implementation of quality
management systems is reports from internal and
external audits. Audits usually highlight the areas
where improvement is necessary and gives an
indication of whether a system is improving
(Konovalova & Popova, 2010).
The chart shows that the total number of nonconformances has steadily decreased between the
WHO Assessment in 2006 and the WHO Peer audit
in 2015. The audit of 2006 revealed 8 nonconformances while that of 2015 revealed only 3
non-conformances in the sample reception unit. Also
of note is that there is an 87.5% reduction in the
number of major non-conformances between 2006
and 2015. The set criterion for this KPI was a 70%
reduction in the severity of (i.e major) nonconformances. This singular KPI gives a clear
indication of improvement in the performance of the
sample receipt process.

Figure 3a Number of Major Non-Conformances observed During
Audits.

Figure 3b Number of Major Non-Conformances observed During
Audits.
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Percentage of samples damaged during
handling
This KPI is a measure of how carefully samples are
handled as they are received into the laboratory. The
chart indicates that there has been a steady
decrease in the percentage of samples damaged
during the sample receipt process. In May, when the
monitoring began, 1.16% of the total numbers of
samples received for that month were damaged
during handling. However by October, it was a 0%
record of damaged samples. This is a 100%
improvement in this KPI. The set criterion for this KPI
is the percentage of samples damaged during
handling at the sample reception area of the Central
Registry should be less than 1% of the total number
of samples received. The unit has thus exceeded
this set criterion
Table 4- Percentage of Samples Damaged During
Handling
Month

Percentage of Samples Damaged
During Handling

May

1.16

June

0.88

July

0.33

August

0.47

September

0.49

October

0

Figure 4 Percentage of Samples damaged During Handling

DISCUSSION
The findings presented above clearly show that there
has been a general improvement in the performance
of the Sample Reception unit. Almost all key
performance indicators monitored during and after
the implementation of the quality management
system showed improvement. The most indicative
KPI is the number and type of non-conformances
observed during audits. The most recent audit of the
sample reception unit, by WHO revealed only one
major non-conformance and 2 minor nonconformances. This is an 87.5% improvement over
the first audit in 2006 where eight major nonconformances were observed.
A 98.14% error-free entries were achieved after the
implementation of QMS as opposed to the 90%
error-free entries observed before the
implementation of QMS. The percentage of samples
damaged during handling steadily declined to 0%.
The environmental conditions of the storage location
for incoming samples were closely monitored to
ensure that the integrity of incoming samples are not
compromised.
However, the indicator for the monitoring of the
efficiency of the unit, that is, the number of samples
inputted within 72hours, did not show consistent
improvement. This indicator was initially improving
from 37% in May to 79% in August and then a sharp
decline to 12.9% in September. Investigations into
this observation showed that there are major
deficiencies in the sample reception unit that has to
be addressed. The first is that the unit does not have
enough qualified and trained staff. The unit relies
heavily on temporary staff to help it in its functions.
Thus in the months where there was a sharp decline
in the speed with which samples were inputted into
the system, it was found that the unit did not have
enough trained personnel to handle all its function.
The second issue was that the unit did not have
enough tools (e.g. high speed computers) to carry
out its functions.
These findings clearly show that the implementation
of a quality management system in the Sample
Reception unit of the Central Registry of the Central
Drug Control Laboratory has greatly improved the
overall effectiveness and efficiency of the unit. It has
ensured that the integrity of incoming samples are
not compromised before testing by the analytical
units. This has led to increased trust and reliability of
the test results and analytical reports produced by
the Central Drug Control Laboratory of the National
Agency for Food and Drugs Administration and
Control.
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It can therefore be concluded that implementing
QMS in the sample reception unit of a
pharmaceutical control laboratories will lead to
improved performance, reliable and accurate test
results.
It is suggested that the monitoring of these KPI
should be continued. The scope of monitoring may
be expanded to include more KPIs that will involve
the whole Central Registry section and not just the
sample reception unit
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